Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioma (Diagnosis)”

2,061 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,061 results

Not applicableTemporarily pausedNCT06129760
What this trial is testing

Glioblastoma Remote Monitoring and Care - Research Protocol

Who this might be right for
GlioblastomaVenous ThromboembolismSeizures
Case Comprehensive Cancer Center 25
Early research (Phase 1)Study completedNCT03154996
What this trial is testing

Chronic Convection Enhanced Delivery of Topotecan

Who this might be right for
Gliomas
Jeffrey N. Bruce 5
Testing effectiveness (Phase 2)Study completedNCT00003537
What this trial is testing

Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma

Who this might be right for
Adult Brain Tumor
Burzynski Research Institute 19
Testing effectiveness (Phase 2)Study completedNCT00050986
What this trial is testing

Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 55
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Not applicableLooking for participantsNCT04648462
What this trial is testing

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

Who this might be right for
AstrocytomaEpendymomaGanglioglioma+9 more
Maastricht Radiation Oncology 1,500
Testing effectiveness (Phase 2)Study completedNCT00004937
What this trial is testing

Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Looking for participantsNCT06815029
What this trial is testing

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma
City of Hope Medical Center 27
Large-scale testing (Phase 3)Study completedNCT00304031
What this trial is testing

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 1,173
Not applicableNot Yet RecruitingNCT07516353
What this trial is testing

My.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

Who this might be right for
SarcomaOsteosarcomaEwing Sarcoma+6 more
Dana-Farber Cancer Institute 143
Testing effectiveness (Phase 2)Ended earlyNCT03352427
What this trial is testing

Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations

Who this might be right for
GliomaHigh Grade GliomaPontine Tumors
University of Michigan Rogel Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00003775
What this trial is testing

Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer 60
Not applicableWithdrawnNCT00985036
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Who this might be right for
GliomaMeningioma
Marquette General Health System
Early research (Phase 1)Not Yet RecruitingNCT07492316
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

Who this might be right for
Recurrent Medulloblastoma
University of Florida 24
Not applicableStudy completedNCT01009307
What this trial is testing

Study of Blood and Cheek Cell Samples From Patients With Glioma

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 1,709
Testing effectiveness (Phase 2)Study completedNCT00352521
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20
Testing effectiveness (Phase 2)Study completedNCT01390948
What this trial is testing

Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma

Who this might be right for
High Grade Glioma
Hoffmann-La Roche 124
Early research (Phase 1)Ended earlyNCT04397679
What this trial is testing

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Barbara Ann Karmanos Cancer Institute 2
Large-scale testing (Phase 3)Active Not RecruitingNCT02685605
What this trial is testing

Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Universitätsmedizin Mannheim 314
Early research (Phase 1)Study completedNCT00075894
What this trial is testing

Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 18
Load More Results